EUVIMEDEUVIMED entdecken
Crossref

The Eradication of Hepatitis C Virus after Liver Transplantation Improved Liver Function and Maintained the Health-related Quality of Life

Atsushi Takai, Yoshihide Ueda, Etsuro Hatano, Hiroshi Seno

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.02.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Atsushi Takai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: atsushit@kuhp.kyoto-u…. Hauptthemen laut MEDLINE: Quality of Life, Liver Transplantation, Antiviral Agents, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Gilead Sciences, Gilead Sciences Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The outcomes of hepatitis C virus eradication and health-related quality of life in the patients treated with direct-acting antivirals (DAAs) after liver transplantation were examined. METHODS: Thirty-five patients with HCV infection treated with sofosbuvir/ledipasvir after liver transplantation were enrolled in the study. The achievement rate of sustained viral response (SVR), liver function and health-related quality of life based on Short-Form-36 version 2 were evaluated. RESULTS: All 35 patients achieved SVR and liver function was improved to a level comparable to that of non-transplanted cases by the DAA treatment. As to health-related quality of life, the scores of general health, vitality and mental health were comparable to Japanese national standard scores among 8 subscales of Short-Form-36 version 2. CONCLUSION: HCV eradication after liver transplantation is useful for not only improving liver function but maintaining health-related quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeLiver TransplantationAntiviral AgentsHepatitis CHepacivirusFluorenesBenzimidazolesLiverHumansMaleMiddle AgedFemaleSofosbuvirAdultTreatment OutcomeSustained Virologic ResponseAgedUridine Monophosphate

Substanzen

Antiviral AgentsSofosbuvirFluorenesBenzimidazolesledipasvir, sofosbuvir drug combinationUridine Monophosphate

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: atsushit@kuhp.kyoto-u.ac.jp.
  • Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kobe University, Kobe, Japan.
  • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Förderung

  • Gilead Sciences
  • Gilead Sciences Inc

Zitieren

APA

Takai, A., Ueda, Y., Hatano, E., & Seno, H. (2025). The Eradication of Hepatitis C Virus after Liver Transplantation Improved Liver Function and Maintained the Health-related Quality of Life. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.02.040

Vancouver

Takai A, Ueda Y, Hatano E, Seno H. The Eradication of Hepatitis C Virus after Liver Transplantation Improved Liver Function and Maintained the Health-related Quality of Life. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.02.040

BibTeX
@article{Takai2025,
  author = {Takai, Atsushi and Ueda, Yoshihide and Hatano, Etsuro and Seno, Hiroshi},
  title = {The Eradication of Hepatitis C Virus after Liver Transplantation Improved Liver Function and Maintained the Health-related Quality of Life},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.02.040}
}
Kostenlos starten →